ANACARDIC ACID

ANACARDIC ACID is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 568 references associated with ANACARDIC ACID in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with ANACARDIC ACID

Download all related citations
Per page 10 20 50 100 | Total 125
Authors Title Published Journal PubMed Link
Kuno A et al. Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein. 2013 J. Biol. Chem. pmid:23297412
Seong YA et al. Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells. 2013 Int. J. Oncol. pmid:23314312
Kim MK et al. Topical application of anacardic acid (6-nonadecyl salicylic acid) reduces UV-induced histone modification, MMP-13, MMP-9, COX-2 and TNF-α expressions in hairless mice skin. 2013 J. Dermatol. Sci. pmid:23228850
Kusio-Kobialka M et al. Inhibition of PCAF by anacardic acid derivative leads to apoptosis and breaks resistance to DNA damage in BCR-ABL-expressing cells. 2013 Anticancer Agents Med Chem pmid:23157591
Hung CH et al. Environmental alkylphenols modulate cytokine expression in plasmacytoid dendritic cells. 2013 PLoS ONE pmid:24039973
Jain S et al. Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival. 2012 Breast Cancer Res. Treat. pmid:22562121
Park WJ and Ma E Inhibition of PCAF histone acetyltransferase and cytotoxic effect of N-acylanthranilic acids. 2012 Arch. Pharm. Res. pmid:22941480
Wisastra R et al. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases. 2012 Bioorg. Med. Chem. pmid:22789707
Omanakuttan A et al. Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9. 2012 Mol. Pharmacol. pmid:22745359
Devipriya B and Kumaradhas P Probing the effect of intermolecular interaction and understanding the electrostatic moments of anacardic acid in the active site of p300 enzyme via DFT and charge density analysis. 2012 J. Mol. Graph. Model. pmid:22306413

Table of Content